Congratulations to Dean's Day winners in the master's category. Receiving first place is Beth Hoffman (BCHS ‘23). Second place was awarded to Kevin Stoner (HPM ‘19). Third place was given to K evin Sullivan (EPI ‘19).
Krista Grobelny (MPH '22) won the master's level award and Mara Hollander (PhD '19) won the doctoral level award.
SSM Health has named Steven M. Scott (HADM '85) as president after he's served as interim president since January. In this role, he is responsible for leading the 356-bed academic medical center that specializes in organ transplant, advanced cancer therapies, and trauma services.
US NEWS & WORLD REPORT- In the 2020 rankings of best graduate schools, Pitt's Master of Health Administration (MHA) program surged from 29th to 17th nationally among programs in health care management. The move was one of the largest in the country, positioning the Pitt MHA as the highest-ranked program in the Commonwealth of Pennsylvania.
MINNESOTA PUBLIC RADIO - Americans spend more on prescription drugs than anyone else in the world, a fact attributed to the ever rising costs of pharmaceuticals. HPM's Walid Gellad, director of the Center for Pharmaceutical Policy and Prescribing, discusses a recent Congressional hearing, in which pharmaceutical executives claim that their hands are tied by the current health care system, and that they need profits to fund new research.
NPR - "With the current awareness and the bipartisan agreement in the recognition of drug prices as a major concern, we are in an optimal environment for the design and implementation of policies targeted at controlling prices, and assuring the affordability of medications to the U.S. public,” states Inmaculada Hernandez (HPM '16). "Financial barriers for medication…are having a detrimental effect on our fellow citizens' health."
PITT WIRE - A recent study led by Inmaculada Hernandez (HPM '16), assistant professor of pharmacy and therapeutics, found that new drugs entering the market drive up prices, but drug companies are also hiking prices on older drugs.
FOX NEWS - "It's not about innovation, it's about inflation in existing products," explains Inmaculada Hernandez (HPM '16). "They are the same companies that operate in other countries and they don't show this behavior and that's because in other countries they are lucky to have this regulatory environment that prevents them from doing this."
NEW YORK TIMES - HPM's Walid Gellad, director of Pitt's Center for Pharmaceutical Policy and Prescribing, calls the policy changes a "watershed moment" and went on to say, "This is highly significant, especially at such a high-profile academic center. Leadership matters, and the institution has decided that their leaders should not also be concurrently leading for-profit health companies."
Congratulations to Mark Sevco (HPM '91) who will be the COO of UPMC Pinnacle in Harrisburg. Sevco was formerly president of UPMC McKeesport in McKeesport, PA and UPMC East in Monroeville, PA.
Read the announcement from Becker's Hospital Review.
WESA - The skyrocketing cost of many prescription drugs in the U.S. can be blamed primarily on price increases, not expensive new therapies or improvements in existing medications as drug companies frequently claim, says a new study published in Health Affairs by Inmaculada Hernandez (HPM '16).
KDKA RADIO - The University of Colorado Hospital announced Christopher A. Gessner (HPM '91), the current president of UPMC Children's Hospital and UPMC Western Psychiatric Hospital, will be their next president and CEO, overseeing the Anschuntz Medical Campus, Broomfield Hospital, Highlands Ranch Hospital, and other outpatient locations in the Denver area.
ALLEGHENY COUNTY MEDICAL SOCIETY BULLETIN - In a perspective piece, HPM's Wendy Braund writes "Something has to change, because what we’re currently doing to stop the opioid epidemic clearly isn’t enough. It’s time for physicians in Allegheny County to embrace harm reduction." She mentions Naloxone, syringe service programs, opioid substitution therapies, and safe injection facilities as options to help end the opioid epidemic.
THE FISCAL TIMES - When drug giant Pfizer announced in July that it would roll back price hikes on its drugs, it made clear that the change was temporary. The company said Friday it is planning to raise the list prices on 41 of its drugs effective January 15. “The drug price pledges made earlier this year were just for show—it was obvious at the time, and it's obvious now,” said HPM's Walid Gellad, director of Pitt's Center for Pharmaceutical Po...
WESA FM - For the first time since 2013, taxpayers won’t be penalized for not having health insurance. Some people might decide ACA-compliant coverage isn't something they need and instead might select a lower-cost “skinny plan.” HPM's Eric Roberts said it’s important to read the fine print before choosing this type of insurance.